McDermott International (MDR) 5.72 $MDR Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
McDermott International (MDR) 5.72 $MDR

Uptrend Call Working As McDermott International Stock Rises 27.1% (MDR)
Comtex SmarTrend(R) - Wed Nov 11, 3:18PM CST
SmarTrend identified an Uptrend for McDermott International (NYSE:MDR) on August 28th, 2015 at $4.63. In approximately 3 months, McDermott International has returned 27.14% as of today's recent price of $5.88.
MDR: 5.72 (+0.07)

McDermott Signs Major EPC Deals in Middle East, Sees Rapid Backlog Growth in Third-Quarter 2015, an Industrial Info News Alert
Marketwired - Wed Nov 11, 6:30AM CST
Researched by Industrial Info Resources (Sugar Land, Texas) -- McDermott International Incorporated (NYSE:MDR) (Houston, Texas), an engineering, procurement and construction (EPC) company focused on offshore oil and gas projects, notched up solid gains in third-quarter 2015 as it touted a slew of contract wins, particularly a record-setting deal in Saudi Arabia, and significant progress at the closely watched INPEX Ichthys project in Australia. Industrial Info is tracking $3.75 billion in projects involving McDermott.
MDR: 5.72 (+0.07)

Watch for McDermott International to Potentially Pullback After Gaining 13.14% Yesterday
Comtex SmarTrend(R) - Tue Nov 10, 5:02PM CST
McDermott International (NYSE:MDR) traded in a range yesterday that spanned from a low of $5.49 to a high of $5.98. Yesterday, the shares gained 13.1%, which took the trading range above the 3-day high of $5.51 on volume of 11.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDR: 5.72 (+0.07)

McDermott (MDR) Gains on Stellar Q3 Earnings, Revenues
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 11:10AM CST
McDermott International Inc. (MDR) reported stellar third-quarter 2015 results. New contracts and improved execution of projects led to the outperformance.
MDR: 5.72 (+0.07), POWR: 13.47 (+0.03), PFIE: 1.27 (+0.07), MTRX: 22.73 (+0.28)

McDermott Int'l (MDR) Stock Up on Earnings Beat
at The Street - Tue Nov 10, 9:52AM CST
McDermott Int'l (MDR) stock is rising on Tuesday after the company reported its 2015 third quarter earnings results.
MDR: 5.72 (+0.07)

McDermott Int’l (MDR) Stock Soars in After-Hours Trading on Earnings Beat
at The Street - Mon Nov 09, 3:31PM CST
McDermott Int’l (MDR) stock is gaining in after-hours trading after the company reported better than expected 2015 third quarter results.
MDR: 5.72 (+0.07)

McDermott Reports Third Quarter 2015 Financial and Operational Results
GlobeNewswire - Mon Nov 09, 3:06PM CST
Lump Sum Award in Saudi Arabia and Two New Awards in Qatar
MDR: 5.72 (+0.07)

McDermott Awarded EPCI Project Offshore Qatar
GlobeNewswire - Mon Nov 09, 3:01PM CST
McDermott International, Inc. (NYSE:MDR) announced today that it has been awarded a large brownfield contract by RasGas Company Limited (RasGas) for the engineering, procurement, construction and installation (EPCI) of a flow assurance and looping project consisting of 74 miles of 6- and 8-inch pipeline and topside modifications, offshore Qatar. Work is scheduled for completion by the end of the third quarter of 2017.
MDR: 5.72 (+0.07)

Can Vanguard Natural Resources (VNR) Q3 Earnings Surprise?
Zacks Equity Research - Zacks Investment Research - Thu Nov 05, 2:15PM CST
Upstream energy partnership Vanguard Natural Resources (VNR) is set to release third-quarter results on Monday, Nov 9.
MDR: 5.72 (+0.07), WRES: 0.34 (+0.01), SDLP: 10.80 (+0.91), VNR: 6.11 (+0.08)

Can Energy XXI (EXXI) Beat Q1 Earnings on Cost Control?
Zacks Equity Research - Zacks Investment Research - Thu Nov 05, 2:00PM CST
We expect domestic oil and gas explorer Energy XXI (EXXI) to beat expectations when it reports first-quarter fiscal 2016 results on Monday, Nov 9.
EXXI: 1.62 (-0.09), MDR: 5.72 (+0.07), WRES: 0.34 (+0.01), SDLP: 10.80 (+0.91)

McDermott International Has Returned 18.8% Since SmarTrend Recommendation (MDR)
Comtex SmarTrend(R) - Wed Nov 04, 10:08AM CST
SmarTrend identified an Uptrend for McDermott International (NYSE:MDR) on August 28th, 2015 at $4.63. In approximately 2 months, McDermott International has returned 18.81% as of today's recent price of $5.50.
MDR: 5.72 (+0.07)

'Mad Money' Lightning Round: I'm Taking Pepsi Over Coke
at The Street - Tue Nov 03, 5:00AM CST
Cramer thinks Mobileye is too expensive, is not a fan of Anadarko's most recent quarter and is avoiding McDermott International.
AMBA: 50.35 (-2.04), KO: 41.38 (-0.20), DVN: 45.05 (-0.01), MDR: 5.72 (+0.07), LNG: 46.12 (+1.24), BAC: 17.20 (-0.17), OZM: 5.70 (-0.09), INTC: 32.11 (-0.29), PEP: 98.04 (-0.33), TXN: 56.13 (-0.54), HAWK: 44.53 (-0.12), MBLY: 42.32 (-1.43), APC: 60.05 (+1.55)

Will Outfront (OUT) Miss Q3 Earnings on Restructuring?
Zacks Equity Research - Zacks Investment Research - Mon Nov 02, 2:37PM CST
Outfront Media Inc. (OUT), formerly CBS Outdoor Americas Inc., is slated to report third-quarter 2015 results after the closing bell on Nov 5
MDR: 5.72 (+0.07), OUT: 22.83 (+0.04), WIN: 5.53 (-0.62), MKL: 853.23 (+10.43)

The Zacks Analyst Blog Highlights: CyberArk Software, McDermott International, Markel and Windstream Holdings
Zacks Equity Research - Zacks Investment Research - Fri Oct 30, 8:30AM CDT
The Zacks Analyst Blog Highlights: CyberArk Software, McDermott International, Markel and Windstream Holdings
MDR: 5.72 (+0.07), CYBR: 38.78 (-1.48), WIN: 5.53 (-0.62), MKL: 853.23 (+10.43)

Occidental (OXY) Jumps on Plans to Exit Williston Basin
Zacks Equity Research - Zacks Investment Research - Thu Oct 29, 5:03PM CDT
Occidental Petroleum (OXY) gained 5.14% yesterday to close at $73.81, thanks to its better-than-expected third-quarter performance and tactical move to exit the Williston Basin operation.
SU: 27.75 (-0.35), MDR: 5.72 (+0.07), OXY: 73.51 (+0.37), MMP: 64.06 (-0.05)

4 Great Stocks Ready to Deliver a Massive Hit This Season
Zacks Equity Research - Zacks Investment Research - Thu Oct 29, 11:48AM CDT
These 4 stocks have posted huge surprises in recent earnings seasons, and they look set to beat estimates this quarter too.
MDR: 5.72 (+0.07), CYBR: 38.78 (-1.48), GOOGL: 740.07 (-16.46), MSFT: 52.84 (-0.48), WIN: 5.53 (-0.62), AAPL: 112.34 (-3.38), MKL: 853.23 (+10.43)

McDermott's Ghana Joint Venture Receives Regulatory Approval
GlobeNewswire - Wed Oct 28, 7:00PM CDT
McDermott International, Inc., (NYSE:MDR) today announced it has received regulatory approval for its McDermott Marine Construction Ghana Limited (MMCGL) joint venture to pursue key offshore opportunities in Ghana. McDermott and MMCGL officials made the announcement during the 2015 Africa Oil Week in Cape Town, South Africa.
MDR: 5.72 (+0.07)

Will Weak End Markets Hurt Eaton Corp's (ETN) Q3 Earnings?
Zacks Equity Research - Zacks Investment Research - Wed Oct 28, 4:18PM CDT
Eaton Corporation plc. (ETN) is scheduled to report third-quarter 2015 results before the opening bell on Oct 30.
MDR: 5.72 (+0.07), ETN: 54.11 (-0.08), LINE: 2.27 (-0.04), PDCE: 58.61 (+1.93)

McDermott Announces Date for Third Quarter 2015 Financial Results and Conference Call
GlobeNewswire - Wed Oct 28, 10:58AM CDT
McDermott International, Inc. (NYSE:MDR) announced today that it plans to issue a press release regarding its financial results for the third quarter 2015 on Monday, November 9, 2015 after the close of trading. The conference call is to begin at 4:00 pm (US Central Time) / 5:00 pm (US Eastern).
MDR: 5.72 (+0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 25

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 116

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 191

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading

Top 5 Most Recently Viewed Articles

Beijing's EV Export Rules Impact NIO and Li Auto Stocks

Updated Category News Views 298

Beijing Implements Stricter EV Export Regulations Affecting Stocks Recently, Chinese electric vehicle (EV) stocks NIO (NYSE: NIO) and Li Auto (NASDAQ: LI) have experienced a notable decline following announcements regarding new regulations by Beijing aimed at tightening the export of EVs. New Export Permit Requirements Effective from January 1, the Ministry of Commerce in...

Continue Reading
OceanaGold Set to Announce Q2 2025 Financial Results Soon

Updated Category News Views 122

Upcoming Financial Results from OceanaGold OceanaGold Corporation (TSX: OGC, OTCQX: OCAND) is gearing up to release its operational and financial results for the second quarter of 2025. This detailed announcement will take place after the market close, and it’s expected to shed light on the company's recent performance and highlight future prospects. Conference Call...

Continue Reading
India's July Industrial Growth Surpasses Expectations by 0.1%

Updated Category News Views 121

India's Industrial Output Shows Promising Growth in July Recent government data reveals that India's industrial output rose by a noteworthy 4.8% year-on-year in July. This figure has drawn attention since it slightly exceeds economists' forecast of 4.7% for the same month. These growing numbers reflect a resilient manufacturing sector that is steadily recovering....

Continue Reading
VideoAmp Extends Partnership with Paramount Global for Measurement

Updated Category News Views 180

VideoAmp and Paramount Global Strengthen Their Collaboration VideoAmp, a pioneering media measurement company, has recently announced the continuation of its long-term collaboration with Paramount Global. This partnership reflects a commitment to evolving the advertising landscape with precise audience insights. Comprehensive Audience Measurement This renewal provides...

Continue Reading
Empire State Realty Trust Delivers Strong Q3 Performance and Guidance

Updated Category News Views 53

Empire State Realty Trust Shows Remarkable Q3 Financial Results Empire State Realty Trust (NYSE: ESRT) demonstrated impressive financial outcomes in its most recent earnings call for the third quarter of 2024, surpassing analyst expectations significantly. The real estate investment trust revealed a Funds From Operations (FFO) totaling $69 million, translating to $0.26...

Continue Reading